FOCUSED ON DEVELOPING AN INNOVATIVE TREATMENT FOR COGNITIVE IMPAIRMENT due to raised cortisol ASSOCIATED WITH NEUROLOGICAL DISEASES Ethics Committee approval for XanaMIA StudyActinogen has received approval from the Bellberry Human Research Ethics Comm...

Biotechnology

Actinogen Medical

Actinogen Medical's headquarters in Sydney, Australia

Steven Gourlay

Will Souter

Andrew Udell

Cheryl Townsend

Fujun Li

Nicki Vasquez

Christopher Chen

Peter Webse

Craig Ritchie

Geoff Brooke

Elizabeth Berry-Kravis

John Harrison

Scott Webster

Brian R Walker

Pamela Ventola

Christina Kurre Olsen

Jonathan Seckl

Jeffrey Cummings

George Morstyn

Malcolm McComas

The Advisory and Governance Team at Actinogen Medical is responsible for providing strategic guidance and oversight for the company's initiatives, particularly in the development of innovative treatments for cognitive impairment. This team, composed of independent directors and advisors, ensures ethical compliance, fosters corporate governance, and facilitates collaboration between stakeholders, ultimately aiding in the successful execution of clinical studies like the XanaMIA Study.

Advisory and Governance

The Clinical Operations team at Actinogen Medical is responsible for overseeing the design, implementation, and management of clinical trials focused on innovative treatments for cognitive impairment. This team collaborates closely with regulatory bodies, ensures compliance with ethical standards, and manages data collection and analysis to support the development of their treatments, such as those evaluated in the XanaMIA Study. Their expertise in clinical research, pharmacology, and regulatory affairs facilitates the advancement of Actinogen's mission to address neurological diseases.

Clinical Operations

Actinogen Medical

Org chart

Board & advisors

Teams

Advisory and Governance

Clinical Operations

Offices

Actinogen Medical

Org chart

Board & advisors

Teams

Advisory and Governance

Clinical Operations

Offices

Related companies